
Naltrexone/bupropion added to a glp-1 agonist or a dpp-4 inhibitor is a reasonable option for weight loss in patients with obesity and type 2 diabetes, a study suggests. Weight loss for diabetes patients. Saxenda was approved as a weight loss medication in 2012 after researchers discovered that patients...